Moderna (MRNA) Return on Capital Employed Growth (3y) (2022 - 2026)
Moderna (MRNA) Return on Capital Employed Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 4,853.00 |
| 10 | Moderna | 22.00 Bn | 16.80 Bn | -566.00 Mn | -5,831.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,831.00 |
| Dec 31, 2025 | -7,478.00 |
| Sep 30, 2025 | -10,218.00 |
| Jun 30, 2025 | -10,850.00 |
| Mar 31, 2025 | -12,774.00 |
| Dec 31, 2024 | -12,818.00 |
| Sep 30, 2024 | -10,858.00 |
| Jun 30, 2024 | -10,187.00 |
| Mar 31, 2024 | -7,408.00 |
| Dec 31, 2023 | 2,092.00 |
| Sep 30, 2023 | 747.00 |
| Jun 30, 2023 | 2,225.00 |
| Mar 31, 2023 | 5,410.00 |
| Dec 31, 2022 | 8,256.00 |
| Sep 30, 2022 | 10,705.00 |
| Jun 30, 2022 | 11,125.00 |
| Mar 31, 2022 | 12,387.00 |